Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8457721 | Nuclear Medicine and Biology | 2018 | 39 Pages |
Abstract
18F-1 exhibited a high specificity for the kidney, rapid renal excretion comparable to that of 131I-OIH and high in vivo radiochemical stability. Not only is 18F-1 a promising PET renal tracer, but it provides a route to the development of a pair of analogous 18F/99mTc renal imaging agents with almost identical structures and comparable pharmacokinetic properties. These promising in vivo results warrant subsequent evaluation in humans.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Malgorzata Lipowska, Nashwa Jarkas, Ronald J. Voll, Jonathon A. Nye, Jeffrey Klenc, Mark M. Goodman, Andrew T. Taylor,